Robert A. Kleczynski - 02 Feb 2026 Form 4 Insider Report for EXELON CORP (EXC)

Signature
David T Skinner, attorney-in-fact for Robert A Kleczynski
Issuer symbol
EXC
Transactions as of
02 Feb 2026
Net transactions value
-$383,378
Form type
4
Filing time
04 Feb 2026, 16:27:14 UTC
Previous filing
26 Feb 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kleczynski Robert A SVP, Controller & Tax 10 S DEARBORN STREET, 54TH FLOOR, CHICAGO David T Skinner, attorney-in-fact for Robert A Kleczynski 04 Feb 2026 0001982165

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise +1,474 +3.6% 42,599 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +1,684 +4% 44,283 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +2,110 +4.8% 46,393 02 Feb 2026 Direct F1
transaction EXC Common Stock Options Exercise +7,019 +15% 53,412 02 Feb 2026 Direct F2
transaction EXC Common Stock Tax liability $165,453 -3,768 -7.1% $43.91 49,644 02 Feb 2026 Direct
transaction EXC Common Stock Disposed to Issuer $217,925 -4,963 -10% $43.91 44,681 02 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2023 Restricted Stock Units Options Exercise -1,474 -100% 0 02 Feb 2026 Common Stock 1,474 Direct F1, F3
transaction EXC 2024 Restricted Stock Units Options Exercise -1,684 -50% 1,683 02 Feb 2026 Common Stock 1,684 Direct F1, F4
transaction EXC 2025 Restricted Stock Units Options Exercise -2,110 -33% 4,218 02 Feb 2026 Common Stock 2,110 Direct F1, F5
transaction EXC 2026 Restricted Stock Units Award $0 +5,673 $0.000000 5,673 02 Feb 2026 Common Stock 5,673 Direct F1
transaction EXC 2023-2025 Performance Shares Award $0 +7,019 $0.000000 7,019 02 Feb 2026 Common Stock 7,019 Direct F2
transaction EXC 2023-2025 Performance Shares Options Exercise -7,019 -100% 0 02 Feb 2026 Common Stock 7,019 Direct F2
holding EXC Deferred phantom share equivalents 1,798 02 Feb 2026 Common Stock 1,798 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit (RSU) award granted under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.
F2 Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
F3 Balance at the time of this vesting includes 53 additional shares acquired through automatic dividend reinvestment during 2025.
F4 Balance at the time of this vesting includes 121 additional shares acquired through automatic dividend reinvestment during 2025.
F5 Balance at the time of this vesting includes 227 additional shares acquired through automatic dividend reinvestment during 2025.
F6 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
F7 Balance as of 12/31/2025 and includes 62 phantom share equivalents accrued during 2025 through automatic dividend reinvestment.